| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 701383 | Null | 0.00423163567577548 | 0.52844893 |
| NSC 707904 | Null | 0.00423163567577548 | 0.4300679 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.00423163567577548 | 0.56173501 |
| NSC 740 | Methotrexate | 0.00423163567577548 | 0.24986222 |
| NSC 140873 | 2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide | 0.00550789647802199 | 0.62447181 |
| NSC 146268 | as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- | 0.00550789647802199 | 0.50898907 |
| NSC 163664 | Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) | 0.00550789647802199 | 0.61893284 |
| NSC 305767 | 2,4-Quinazolinediamine, 6-[(4-chlorophenyl)thio]- | 0.00550789647802199 | 0.14637102 |
| NSC 382006 | Null | 0.00550789647802199 | 0.71131137 |
| NSC 615538 | ANTINEOPLASTIC-615538 | 0.00550789647802199 | 0.33332819 |